Table 4.
Biomarker profiling for the 5 C4Nef-positive patients
Patient No. | C3, g/L (ref 0.9–1.8) | C3c, mg/L (ref < 2) | C4, g/L (ref 0.15–0.47) | C4a, mg/L (ref <0.72) | C2, mg/L (ref 34–50) | fB, mg/L (ref 155–250) | Ba, mg/L (ref <1.2) | Bb, mg/L (ref <1.2) | C5, mg/dL (ref 55–125) | P, mg/L (ref 11–33) | sC5b-9, mg/L (ref <0.3) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | <0.1 | 2.3 | 0.18 | 0.17 | 35.3 | 200 | 0.3 | 0.9 | 39.5 | 9.3 | 1.6 |
2 | 0.25 | 2.0 | 0.45 | 0.78 | 27.1 | 171 | 2.0 | 2.0 | 40.2 | 8.4 | 2.8 |
3 | 0.4 | 2.7 | 0.24 | 0.71 | 38.2 | 163 | 1.2 | 2.0 | 35.5 | 10.3 | 1.9 |
4 | 0.65 | 2.1 | 0.34 | 1.22 | 35.7 | 158 | 1.4 | 1.3 | 61.7 | 21.3 | 0.8 |
5 | 0.11 | 3.4 | 0.19 | 0.25 | 35.9 | 225 | 0.7 | 1.1 | 24.9 | 10.5 | 1.9 |
Note: Date of testing as for Table 3; normal reference (ref) values are listed under each biomarker C4NeF, C4 nephritic factor